Pharmocotherapy Principles and Practice- Peptic Ulcer Disease

Contact Hours: 1.5

ACPE No: 014-999-07-028-H04

Activity Type:

Release Date:
Expiration Date:

Learning Objectives

Upon completion of this activity the participant should be able to:
Upon completion of the chapter the reader will be able to:
1. Recognize differences between ulcers induced by Helicobacter pylori (HP) and nonsteroidal anti-inflammatory drugs (NSAIDs) in terms of risk factors, pathogenesis, signs and symptoms, clinical course, and prognosis.
2. Identify desired therapeutic outcomes for patients with HP-associated ulcers and NSAID-induced ulcers.
3. Identify factors that guide selection of an HP eradication regimen and improve compliance with these regimens.
4. Determine the appropriate management for a patient taking a nonselective NSAID who is at high risk for ulcer-related gastrointestinal complications or who develops an ulcer.
5. Devise an algorithm for evaluation and treatment of a patient with signs and symptoms suggestive of an HP-associated or NSAID-induced ulcer.
6. Given patient-specific information and the prescribed drug treatment regimen, formulate a monitoring plan for a patient who is receiving drug therapy to either eradicate HP or to treat an active NSAID-induced ulcer or gastrointestinal complication.

Faculty:

Computer Requirements for Online Courses
PC


MAC

Acpelogo The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.